Careers
Contact Us
About Us
Management Team
Board of Directors
Our History
Our Impact
Compliance & Quality
Our Products
Marketed
Pipeline opportunities
Medical Affairs
Publications
Research Grants
Clinical Trials
Contact Medical Affairs
Investors
Press Releases
Presentations and Events
Investor FAQ
Analyst Coverage
Stock Information
SEC Filings
Medical Affairs
Publications
Research Grants
Clinical Trials
Contact Medical Affairs
Careers
Contact Us
Home
>
Investors & Media
Press Releases
Review corporate releases related to governance, investor news, and other important announcements.
All
2026
2025
2024
2023
Jul 29, 2026
CORMEDIX THERAPEUTICS TO REPORT SECOND QUARTER 2026 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON AUGUST 13, 2026
Read more
Jun 08, 2026
U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT AFFIRMS VICTORY FOR CORMEDIX THERAPEUTICS IN MINOCIN® PATENT LITIGATION
Read more
May 14, 2026
CORMEDIX THERAPEUTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Read more
May 05, 2026
CORMEDIX THERAPEUTICS TO REPORT FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON MAY 14, 2026
Read more
Apr 27, 2026
CORMEDIX THERAPEUTICS ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE III RESPECT TRIAL ASSESSING REZZAYO® FOR THE PROPHYLAXIS OF INVASIVE FUNGAL DISEASES IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS
Read more
Apr 07, 2026
CORMEDIX TO PARTICPATE IN NEEDHAM VIRTUAL HEALTHCARE CONFERENCE
Read more
Mar 05, 2026
CORMEDIX INC. REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Read more
Mar 02, 2026
CORMEDIX INC. TO REPORT FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON MARCH 5, 2026
Read more
Feb 12, 2026
CORMEDIX TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
Read more
Feb 02, 2026
CORMEDIX THERAPEUTICS ANNOUNCES SHARE REPURCHASE PROGRAM
Read more
See more
You have clicked on an external link and will be taken offsite.
Would you like to proceed?
CONTINUE
Cancel